Johnson & Johnson said on Tuesday it would halt sale of personal care products in Russia, joining other companies that have limited their business in the country in response to its invasion of Ukraine. J&J said it would continue to supply medicines and medical devices in the region as those are excluded from Western sanctions. It will, however, not enroll more patients in clinical drug trials it was running in Russia, it said earlier. The company, which gets about 1 percent of its sales from Russia, has previously said that half of its business in the region is pharmaceuticals and a majority of its product portfolio from its consumer health business comes within the essential health space of over-the-counter medicines. J&J is one of the biggest drugmakers in the world and also has a sizeable consumer health business that sells skin care, beauty, and oral care products under brands including …